DEEP TRACK BIOTECHNOLOGY MASTER FUND, LTD. reported 1 transaction at ATTOVIA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/10/2026ACC: 0001193125-26-342487
→
10% Owner
Since Aug 2026
-16.22M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.96M acquired · 18.18M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.96M
Price / share
—
Trade value
—
% of position
New position
8/6/2026
0.00→1.96M
Total
Net shares
+1.96M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/6/2026 | C · Conversion | +1.96M | — | — | New position | 0.00 | 1.96M |
| Total | +1.96M | $0.00 | ||||||
Derivative Transactions1
Series C Redeemable Convertible Preferred Stock
Direct
Converts to
Common Stock
1.96M shares
Shares
−18.18M
Strike price
Held after
N/A
Exercisable
—
8/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series C Redeemable Convertible Preferred Stock Direct | Common Stock1.96M shares | 8/6/2026 | C · Conversion | −18.18M | — | N/A |